Developments, news and strategies for drug development specific to phase I through Phase III global clinical trial management, execution, project management and outsourcing. Go→
News, articles and issues specific to clinical trial practice and implementation at the investigative site level. Go→
News, developments and strategies related to eClinical, data management, data collection, ePRO, and more information technology used in the drug development chain. Go→
News, articles and issues specific to laboratories role in the clinical trial, including ECG, imaging, genotyping, tissue samples and more. Go→
News, developments and strategies for clinical trials conduct in relation to the FDA, EMEA and other global regulatory authorities overseeing the drug development industry. Go→
News, articles and strategies related to clinical trial design which impact postmarketing studies, therapeutic areas, adaptive trials, statistics, protocols and more. Go→
|
|
Studies Published in Pain Medicine Demonstrate Effectiveness of Minimally-Invasive Cooled Radiofrequency Treatment for Low Back Pain
Publish date: Mar 1, 2013
![]()
PR Newswire ROSWELL, Ga., March 1, 2013
ROSWELL, Ga., March 1, 2013 /PRNewswire/ -- Kimberly-Clark
today announced the publication of two separate studies that achieved positive outcomes following use of cooled radiofrequency (RF) to treat discogenic and sacroiliac joint (SIJ) pain in the low back. The studies
evaluated Kimberly-Clark's TransDiscal Cooled Radiofrequency
System and SInergy Cooled Radiofrequency System and demonstrated that both treatment options provided patients who suffer
from chronic low back pain with much-needed pain relief and improved quality of life benefits. Results were published in Pain
Medicine, the official journal of the American Academy of Pain Medicine, the Faculty of Pain Medicine of the Australian
and New Zealand College of Anesthetists, and the International Spine Intervention Society. (Logo: http://photos.prnewswire.com/prnh/20110928/DA76879LOGO) Dr. Leonardo Kapural of Carolinas Pain Institute and Wake Forest Brookstown Pain Center
in Winston-Salem, N.C., led the first-of-its-kind double-blinded randomized controlled trial study of 59 patients with 29 randomized to intradiscal
biacuplasty (IDB) and 30 to the control group. Participating patients had a history of chronic low back pain persisting six
months or longer. This type of pain is extremely debilitating, and it dramatically limits an individual's everyday activities
such as sitting and driving. At the six-month follow-up, patients treated with Kimberly-Clark's TransDiscal Cooled RF System reported significantly greater improvements in restoration
of physical function, and a decrease in pain, disability and opioid usage compared to patients in the control group. The study
was conducted at the Department of Pain Management at the Cleveland Clinic in Cleveland, Ohio,
and the Center for Clinical Research at Carolina's Pain Institute in Winston-Salem. "Discogenic low back pain accounts for the majority of chronic low back pain. Traditional treatment options include pharmacologic,
physiotherapy and surgical options such as spinal fusion or artificial disc replacement. These data are particularly encouraging
because there is now additional, compelling evidence to suggest a minimally-invasive approach, such as cooled radiofrequency,
can provide sustained relief to a carefully selected group of patients," said lead clinical investigator Leonardo Kapural, M.D., Ph.D. "In this study, patients treated with the TransDiscal Cooled RF System experienced
clinically significant improvements in physical function compared to those in the control group." In the same edition of Pain Medicine, a retrospective chart review found the use of cooled RF to be significantly
effective for the treatment of SIJ low back pain. The European study, led by Dr. Wolfgang Stelzer of the Medical University of Vienna,
Austria, examined the electronic records of 126 patients treated with Kimberly-Clark's SInergy Cooled RF System for SIJ pain. The retrospective chart review showed promising,
durable improvements in pain, quality of life and reduction in medication usage. At the one-year follow-up, 67 percent of patients stopped or decreased use of opioids, 48 percent of patients reported
significant reduction in pain scores and 85 percent stated quality of life was improved or much improved. In some patients,
relief was maintained up to 20 months. These results echo published study findings from Dr. Nilesh Patel of Advanced Pain Management
in Green Bay, Wis., in which patients treated with the SInergy Cooled RF System showed significant
improvements in pain, disability and quality-of-life outcomes at the three-month mark. Durability of relief was maintained
at the nine-month follow-up and 59 percent achieved treatment success[i]. Low back pain is the second most common cause of disability in U.S. adults[ii] and a common reason for lost work days[iii],
[iv]. Cooled RF is a minimally-invasive non-pharmacological treatment option for those suffering from low back pain. RF energy
heats the nerve tissue while circulating water moderates the temperature in close proximity to the electrode. This combination
creates large volume lesions without excessive heating at the electrode. Patients are typically placed under little-to-no
sedation and are released the same day. "The promising results from these two studies further validate the effectiveness and role of cooled radiofrequency as a
minimally-invasive treatment option for low back pain," said Lisa Kudlacz, General Manager,
Global Interventional Pain Management, Kimberly-Clark Health Care. "Patients with difficult-to-treat, chronic low back pain
have an option that has demonstrable benefits — reduction in medication usage, significant improvement in quality of
life and improved functionality — to get back to their active lifestyles."
Kimberly-Clark in the Healthcare Environment
Around the world, medical professionals turn to Kimberly-Clark
for a wide portfolio of solutions that improve the health, hygiene and well-being of their patients and staff. As part of
their healing mission, caregivers rely on Kimberly-Clark
to deliver clinical solutions, hygiene & cleaning offerings, and educational resources that they can depend on to prevent,
diagnose and manage a wide variety of healthcare-associated infections. This more than $1 billion
global enterprise of Kimberly-Clark Corporation holds the No. 1 or No. 2 market share position in several categories, including
infection control solutions, surgical solutions, pain management, hygiene solutions and digestive health. And throughout the
care continuum, patients and staff alike trust Kimberly-Clark
medical supplies and devices, KLEENEX tissues, KLEENEX & SCOTT skin care products and SCOTT towels for day-to-day needs.
For more information, visit http://www.kchealthcare.com and http://www.kcprofessional.com.
About Kimberly-Clark
[i] Patel, N., A Randomized, Placebo-Controlled Study to Assess the Efficacy of Lateral Branch Neurotomy for Chronic Sacroiliac
Joint Pain., Pain Medicine, March 2012, V. 13, Issue 3, pages 383–398. [ii] From the Centers for Disease Control and Prevention, Prevalence of disabilities and associated health conditions among
adults—United States, 1999. JAMA 2001;285 (12) 1571- 1572 [iii] Stewart WFRicci JAChee EMorganstein DLipton R Lost productive time and cost due
to common pain conditions in the US workforce. JAMA 2003;290 (18) 2443- 2454 [iv] Ricci JAStewart WFChee ELeotta CFoley KHochberg MC Back pain exacerbations
and lost productive time costs in United States workers. Spine 2006;31 (26) 3052- 3060 SOURCE Kimberly-Clark
|
|